X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
cardiac & cardiovascular systems (20) 20
female (20) 20
male (20) 20
aged (18) 18
middle aged (18) 18
risk factors (17) 17
stroke (10) 10
cardiovascular disease (9) 9
secondary prevention (9) 9
cardiac rehabilitation (8) 8
cardiovascular diseases (8) 8
mortality (8) 8
prevention (8) 8
abridged index medicus (7) 7
blood pressure (7) 7
cardiovascular diseases - prevention & control (7) 7
europe - epidemiology (7) 7
guidelines (7) 7
health risk assessment (7) 7
management (7) 7
myocardial-infarction (7) 7
treatment outcome (7) 7
adult (6) 6
clinical medicine (6) 6
evidence-based medicine (6) 6
guideline adherence (6) 6
klinisk medicin (6) 6
myocardial infarction (6) 6
prevalence (6) 6
surveys and questionnaires (6) 6
association (5) 5
cardiovascular (5) 5
cerebral infarction (5) 5
coronary heart disease (5) 5
cross-sectional studies (5) 5
diabetes mellitus (5) 5
disease (5) 5
double-blind method (5) 5
europe (5) 5
incidence (5) 5
medicine, general & internal (5) 5
metaanalysis (5) 5
practice guidelines as topic (5) 5
risk assessment (5) 5
artery-disease (4) 4
cardiac and cardiovascular systems (4) 4
cardiology (4) 4
clinical-practice (4) 4
coronary artery disease (4) 4
coronary disease - epidemiology (4) 4
diabetes (4) 4
epidemiology (4) 4
euroaspire (4) 4
events (4) 4
glucagon (4) 4
glucagon-like peptide 1 (4) 4
heart attacks (4) 4
heart diseases - rehabilitation (4) 4
hemoglobin (4) 4
kardiologi (4) 4
motivation (4) 4
prognosis (4) 4
risk (4) 4
risk-factors (4) 4
smoking-cessation (4) 4
therapy (4) 4
adolescent (3) 3
agonists (3) 3
aspirin (3) 3
aspirin - administration & dosage (3) 3
aspirin - adverse effects (3) 3
cardiovascular diseases - epidemiology (3) 3
cardiovascular diseases - mortality (3) 3
case-control studies (3) 3
clinical trials (3) 3
coronary-heart-disease (3) 3
diabetes mellitus, type 2 - drug therapy (3) 3
disease control (3) 3
drug administration schedule (3) 3
endocrinology & metabolism (3) 3
exercise (3) 3
health policy (3) 3
hypertension (3) 3
hypoglycemic agents - therapeutic use (3) 3
kidney diseases (3) 3
life expectancy (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
morbidity - trends (3) 3
outcomes (3) 3
patients (3) 3
peptides (3) 3
population (3) 3
public health (3) 3
rehabilitation (3) 3
risk analysis (3) 3
risk reduction behavior (3) 3
rivaroxaban - administration & dosage (3) 3
rivaroxaban - adverse effects (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10046, pp. 761 - 775
Summary Background Stroke is a leading cause of death and disability, especially in low-income and middle-income countries. We sought to quantify the... 
Internal Medicine | ETHNIC-DIFFERENCES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | CARDIOVASCULAR-DISEASE | ALCOHOL-CONSUMPTION | DIETARY PATTERNS | ISCHEMIC-STROKE | BURDEN | HEMORRHAGIC STROKE | BLOOD-PRESSURE | ATRIAL-FIBRILLATION | Humans | Middle Aged | Male | Apolipoproteins B - blood | Motor Activity | Cerebral Hemorrhage - blood | Hypertension - blood | Stroke - pathology | Brain Ischemia - blood | Obesity, Abdominal - epidemiology | Odds Ratio | Waist-Hip Ratio | Brain Ischemia - complications | Brain Ischemia - epidemiology | Risk Factors | Self Report | Atrial Fibrillation - complications | International Cooperation | Biomarkers - blood | Evidence-Based Medicine | Health Behavior | Stroke - etiology | Obesity, Abdominal - complications | Cerebral Hemorrhage - complications | Smoking - adverse effects | Africa - epidemiology | Case-Control Studies | Diabetes Complications - epidemiology | Adult | Female | Stroke - epidemiology | Hypertension - epidemiology | Diabetes Complications - prevention & control | Stroke - prevention & control | Risk Reduction Behavior | Europe - epidemiology | Feeding Behavior | China - epidemiology | Alcohol Drinking - adverse effects | Australia - epidemiology | Stroke - blood | Middle East - epidemiology | Asia - epidemiology | Atrial Fibrillation - epidemiology | Cerebral Hemorrhage - epidemiology | Alcohol Drinking - epidemiology | Smoking - epidemiology | Hypertension - complications | Aged | Apolipoprotein A-I - blood | Stroke (Disease) | Risk factors | Studies | Pathology | Stroke | Preventive medicine | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article
European journal of cardiovascular prevention and rehabilitation, ISSN 1741-8267, 2010, Volume 17, Issue 4, pp. 410 - 418
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 01/2018, Volume 20, Issue 1, pp. 42 - 49
Journal Article
by Bosch, Jackie, MSc, PhD and Eikelboom, John W., MBBS, MSc and Connolly, Stuart J., MD and Cook Bruns, Nancy, MD and Lanius, Vivian, PhD and Yuan, Fei, MMath and Misselwitz, Frank, MD, PhD and Chen, Edmond, MD and Diaz, Rafael, MD and Alings, Marco, MD, PhD and Lonn, Eva M., MD, MSc and Widimsky, Petr, MD, DSc and Hori, Masatsugu, MD, PhD and Avezum, Alvaro, MD, PhD and Piegas, Leopoldo S., MD and Bhatt, Deepak L., MD, MPH and Branch, Kelley R.H., MD, MSc and Probstfield, Jeffrey L., MD and Liang, Yan, MD and Liu, Lisheng, MD and Zhu, Jun, MD and Maggioni, Aldo P., MD and Lopez-Jaramillo, Patricio, MD, PhD and O’Donnell, Martin, MB, PhD and Fox, Keith A.A., BSc, MBChB and Kakkar, Ajay, MBBS, PhD, BSc, MA and Parkhomenko, Alexander N., MD, PhD and Ertl, Georg, MD and Störk, Stefan, MD, PhD and Keltai, Katalin, MD and Keltai, Matyas, MD and Ryden, Lars, MD and Dagenais, Gilles R., MD and Pogosova, Nana, MD, PhD and Dans, Antonio L., MD, MSc and Lanas, Fernando, PhD and Commerford, Patrick J., MBChB and Torp-Pedersen, Christian, MD and Guzik, Tomasz J., MD, PhD, MSc and Verhamme, Peter B., MD and Vinereanu, Dragos, MD, PhD and Kim, Jae-Hyung, MD, PhD and Ha, Jong-Won, MD, PhD and Tonkin, Andrew M., MD, MBBS and Varigos, John D., BSc (Hon) and Lewis, Basil S., MD and Felix, Camilo, MD, MSc and Yusoff, Khalid, MBBS and Steg, Philippe Gabriel, MD and Aboyans, Victor, MD, PhD and Metsarinne, Kaj P., MD, PhD and Anand, Sonia S., MD, PhD and Hart, Robert G., MD and Lamy, Andre, MD, MHSc and Moayyedi, Paul, BSc, MBChB, PhD and Sharma, Mukul, MD, MSc and Yusuf, Salim, MBBS,-DPhil
Canadian Journal of Cardiology, ISSN 0828-282X, 2017, Volume 33, Issue 8, pp. 1027 - 1035
Journal Article
European journal of preventive cardiology, ISSN 2047-4881, 2015, Volume 23, Issue 6, pp. 636 - 648
Journal Article
European journal of preventive cardiology, ISSN 2047-4881, 2014, Volume 22, Issue 10, pp. 1290 - 1306
Journal Article
European journal of epidemiology, ISSN 1573-7284, 2018, Volume 34, Issue 3, pp. 247 - 258
Journal Article
by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Ryden, Lars and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and VOGEL, DANIEL and HRABAR, ADRIAN and CUNEO, CARLOS and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and CARDONA, MARCELO and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and ABRANTES, JOSE ANTONIO and MANENTI, EULER and MAIA, LILIA and HERNANDES, MAURO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and ABIB JR, EDUARDO and LEAES, PAULO and BOTELHO, ROBERTO and BRAILE, MARIA and IZUKAWA, NILO and TANAJURA, LUIZ FERNANDO and SERRANO JUNIOR, CARLOS VICENTE and NASI, LUIZ ANTONIO and TYTUS, RICHARD and PANDEY, SHEKHAR and LONN, EVA and CHA, JAMES and BABAPULLE, MOHAN and LAMY, ANDRE and KIAII, BOB and BHARGAVA, RAKESH and MEHTA, PRAVINSAGAR and HILL, LAURIE and FELL, DAVID and LAM, ANDY and AL-QOOFI, FAISAL and PETRELLA, ROBERT and GLANZ, ANTHONY and NOISEUX, NICOLAS and MERALI, FATIMA and ... and COMPASS Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet (British edition), ISSN 0140-6736, 2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Evidence-based medicine | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Cardiovascular Diseases | Factor Xa Inhibitors